Role of cytokines as markers for immunomodulation in patients with hepatitis C
Bulletin of High Institute of Public Health [The]. 2002; 32 (4): 833-846
Dans Anglais
| IMEMR
| ID: emr-59046
ABSTRACT
In the present study, soluble interleukin-2 receptor [sIL-2R] and tumor necrosis factor-alpha [TNF-a] were measured in serum by ELISA and alpha fetoprotein was assessed by RIA in 20 patients with hepatitis C virus [HCV] infection, in addition to 10 apparently healthy subjects served as controls. The results showed an increased serum level of sIL-2R in the patients group [783.65 U/ml] than in the control subjects [774.19 U/ml]. In the same time, the mean level of TNF-alpha was also significantly elevated in patients [1.51 +/- 1.01] than in the controls [0.39 +/- 0.07 ng/ml]. Furthermore, 3 out of 20 HCV +ve patients had an elevated serum alpha-fetoprotein [AFP]
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Test ELISA
/
Dosage radioimmunologique
/
Récepteurs à l'interleukine-2
/
Alphafoetoprotéines
/
Adjuvants immunologiques
/
Cytokines
/
Facteur de nécrose tumorale alpha
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Bull. High Inst. Public Health
Année:
2002
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS